Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors. (Record no. 21592487)

MARC details
000 -LEADER
fixed length control field 01580 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250516081757.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 201208s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1873-5576
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.2174/156800912800190929
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Bagnasco, L
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20120808
245 00 - TITLE STATEMENT
Title Role of angiogenesis inhibitors in colorectal cancer: sensitive and insensitive tumors.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Current cancer drug targets
Date of publication, distribution, etc. May 2012
300 ## - PHYSICAL DESCRIPTION
Extent 303-15 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adenomatous Polyposis Coli
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Angiogenesis Inhibitors
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Animals
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Monoclonal, Humanized
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Agents
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Bevacizumab
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Biomarkers, Tumor
General subdivision analysis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Colorectal Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mice
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neovascularization, Pathologic
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Treatment Outcome
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Vascular Endothelial Growth Factor A
General subdivision antagonists & inhibitors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Piras, D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Parodi, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bauer, I
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Zoppoli, G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Patrone, F
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Ballestrero, A
773 0# - HOST ITEM ENTRY
Title Current cancer drug targets
Related parts vol. 12
-- no. 4
-- p. 303-15
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.2174/156800912800190929">https://doi.org/10.2174/156800912800190929</a>
Public note Available from publisher's website

No items available.